|
Volumn 96, Issue 2, 2002, Pages 169-183
|
Process development of a recombinant antibody/interleukin-2 fusion protein expressed in protein-free medium by BHK cells
c
MERCK KGAA
(Germany)
|
Author keywords
BHK cells; EGF receptor; Pharmacokinetics; Purification; Recombinant fusion protein; Tumour immunotherapy; Tumour targeted therapy
|
Indexed keywords
ANTIBODIES;
CHEMOSTATS;
MASS SPECTROMETRY;
PURIFICATION;
TUMORS;
FUSION PROTEIN;
GLYCOSYLATION;
RECOMBINANT ANTIBODY;
BIOTECHNOLOGY;
HYBRID PROTEIN;
RECOMBINANT ANTIBODY;
RECOMBINANT INTERLEUKIN 2;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CANCER THERAPY;
CELL LINE;
CELL STRAIN BHK;
CHEMOSTAT;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG STRUCTURE;
DRUG SYNTHESIS;
GLYCOSYLATION;
MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;
MOUSE;
NONHUMAN;
POLYACRYLAMIDE GEL ELECTROPHORESIS;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
PROTEIN PURIFICATION;
PROTEIN QUALITY;
PROTEIN STABILITY;
PROTEIN STRUCTURE;
PROTEIN SYNTHESIS;
WESTERN BLOTTING;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BIOREACTORS;
CELL CULTURE TECHNIQUES;
CELL DIVISION;
CELL LINE;
CELL-FREE SYSTEM;
CHROMATOGRAPHY, ION EXCHANGE;
CRICETINAE;
GLYCOSYLATION;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN HEAVY CHAINS;
INTERLEUKIN-2;
KIDNEY;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
OLIGOSACCHARIDES;
PERFUSION;
RECOMBINANT FUSION PROTEINS;
SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;
TUMOR CELLS, CULTURED;
|
EID: 18444382663
PISSN: 01681656
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-1656(02)00028-7 Document Type: Article |
Times cited : (18)
|
References (29)
|